1. Home
  2. SA vs AVDL Comparison

SA vs AVDL Comparison

Compare SA & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seabridge Gold Inc. (Canada)

SA

Seabridge Gold Inc. (Canada)

HOLD

Current Price

$29.67

Market Cap

2.7B

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.57

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SA
AVDL
Founded
1979
2015
Country
Canada
Ireland
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SA
AVDL
Price
$29.67
$21.57
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$65.00
$18.38
AVG Volume (30 Days)
1.1M
1.6M
Earning Date
11-12-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$248,517,000.00
Revenue This Year
N/A
$65.47
Revenue Next Year
N/A
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.88
52 Week Low
$9.40
$6.38
52 Week High
$31.87
$23.57

Technical Indicators

Market Signals
Indicator
SA
AVDL
Relative Strength Index (RSI) 55.24 60.27
Support Level $28.31 $21.36
Resistance Level $31.87 $21.67
Average True Range (ATR) 1.44 0.12
MACD -0.07 -0.10
Stochastic Oscillator 48.90 70.89

Price Performance

Historical Comparison
SA
AVDL

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: